Trizolin

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Trizolin

What is Trizolin? An Overview

Property Description
Active ingredient Norfloxacin
Form Film-coated tablet; Ophthalmic solution
Pharmacological class Fluoroquinolone Antibiotic
Common use Combating bacterial infections
Origin Synthetic

What Type of Medicine is Trizolin?

Trizolin is a medicinal preparation formulated as a synthetic antibacterial agent belonging to the fluoroquinolone class of antibiotics. Its composition is based on the single active ingredient, Norfloxacin, which defines its potent anti-infective properties. Norfloxacin's chemical structure identifies it as a quinolone antibiotic and its classification as a fluoroquinolone signifies that it is a chemically manufactured, synthetic compound, deliberately designed to target bacterial pathogens, distinguishing it from antibiotics derived from natural sources.

Drugs containing Norfloxacin are indicated for treating infections caused by susceptible bacteria. This prescription-only medicine is clinically recognized for its broad activity, which has been supported by numerous pharmacological studies. Trizolin is categorized as a single-ingredient product and is valued for its broad-spectrum capability to kill a wide variety of harmful bacteria, a characteristic common to the fluoroquinolone group.


Trizolin's Form and General Purpose

Trizolin is manufactured in two primary high-level dosage forms to accommodate distinct routes of administration: a film-coated tablet designed for oral administration, and an ophthalmic solution for topical ocular administration. The general purpose of Trizolin is to provide a powerful bactericidal effect (the capacity to kill bacteria) against susceptible infectious organisms. Its primary function is to help the body resolve and eliminate bacterial proliferation, thereby providing effective resolution against established bacterial infections, such as those impacting the urinary system.

Norfloxacin acts by inhibiting bacterial DNA synthesis, leading to cell death. This confirms that the medicine works to eliminate the source of the infection by preventing bacteria from reproducing. The availability of both an oral, systemically acting form and a localized ocular preparation is a differentiating factor, ensuring the active agent, Norfloxacin, can be delivered appropriately to the specific site of need.

Regulatory References

  1. WHO Essential Medicines List classification for Norfloxacin

What side effects are possible with Trizolin?

Possible Side Effects and Safety Information

The safety profile of Trizolin, which contains the active ingredient Norfloxacin, is formally classified by regulatory authorities based on the frequency and the System-Organ Class (SOC) affected. The documented adverse reactions cover several physiological systems, including gastrointestinal, nervous system, and musculoskeletal.

Frequency-Classified Adverse Reactions

Official labeling categorizes side effects by incidence rates:

  • Common (e.g., in ge 1/100 to <1/10 treated patients) effects include Nausea, Headache, and Dizziness.
  • Uncommon effects may include abdominal pain, diarrhea, insomnia, and the temporary elevation of liver enzymes.
  • Rare adverse reactions documented in regulatory sources include Paresthesia (a tingling sensation), Photosensitivity reactions, and Tendon rupture.

Serious Adverse Reactions and Safety Constraints

The official label highlights several reactions due to their potential severity. As a fluoroquinolone, Trizolin is associated with the risk of Tendon rupture, a serious event documented to occur during or even after the completion of the treatment course. Other serious reactions include severe systemic Anaphylactic reactions and significant Central Nervous System disturbances, such as the potential for Seizures.

Regulatory documents specify that use is generally contraindicated in individuals with a known history of hypersensitivity to Norfloxacin or to any medicinal product belonging to the fluoroquinolone class.

Population-Specific Considerations

Certain groups may face heightened safety considerations as noted in official prescribing information. Older adults are documented to be at a potentially higher risk of tendon rupture. Additionally, patients with existing renal impairment require careful monitoring, given that the medicine is primarily excreted through the kidneys.

Overdose and Emergency Response

Overdose and When to Seek Help

Regulatory documents state that a suspected acute overdosage of Trizolin (Norfloxacin) requires immediate medical attention. Management of overdosage is focused on symptomatic and supportive treatment, as regulatory agencies document that no specific antidote is known.

The clinical presentation of overdosage may vary by regulatory jurisdiction; while some labels have documented specific manifestations such as vomiting, diarrhoea, dizziness, tinnitus, and convulsions, other authorities note that definitive signs and symptoms have not been identified. Significant poisoning carries the documented risk of severe outcomes, including acute renal failure and liver damage. For this reason, urgent medical evaluation is necessary.

Medical professionals managing an overdosage may utilize procedures such as gastric lavage or the administration of activated charcoal. Furthermore, regulatory guidance emphasizes the necessity of careful observation and maintaining adequate hydration to reduce the risk of crystalluria. Pharmacokinetic data indicates that elimination of Norfloxacin is slower in the elderly due to reduced renal function, which may increase systemic exposure during an overdose.

Therapeutic Uses of Trizolin

What Trizolin Treats: Main Uses and Benefits

Trizolin is generally used to help manage symptoms associated with conditions where symptoms may intensify temporarily. The medicine may be applied in addressing conditions characterized by periods of heightened symptoms and is relevant in clinical settings where short-term symptomatic assistance is needed.


Easing Discomfort and Supporting Stability

Trizolin is applicable in contexts marked by increased discomfort or tension, associated with conditions involving episodic or fluctuating manifestations. It is applied in addressing situations involving recurrent or episodic manifestations, and contributes to easing the overall symptom load. Patients may assist with maintaining a sense of stability when symptoms that interfere with daily functioning are more noticeable. This supportive relief supports general well-being during these episodes.

“Trizolin supports the patient during difficult episodes by easing distress.”


Quick Fact: Supports Against Systemic Strain

Trizolin is considered relevant for symptom clusters that may become intense or disruptive, such as those that create noticeable physiological strain. It helps ease associated symptoms and assists with maintaining functional stability during symptomatic periods.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Trizolin

Official regulatory documents define strict limitations on who is eligible to use Trizolin, an antibiotic containing Norfloxacin.

Eligibility Classification Population Status Regulatory Basis
Contraindicated Patients with a history of hypersensitivity to Norfloxacin or any other quinolone antibiotic. Absolute Exclusion
Contraindicated Patients with a history of tendinitis or tendon rupture related to any prior fluoroquinolone use. Absolute Exclusion
Not Recommended Children and adolescents (under 18 years of age). Safety/Efficacy Not Established
Contraindicated Women who are pregnant or breastfeeding. Insufficient Safety Data
Conditional Use Patients with severe renal impairment (Creatinine Clearance le 30 mL/min). Requires Dose Adjustment
Conditional Use Patients with a history of Myasthenia Gravis or risk factors for seizures or QT prolongation. Caution Required

Connection to the overall eligibility profile:

Regulatory authorities structure Trizolin's eligibility by listing absolute exclusions for those with drug-class hypersensitivity and tendon history. The label also imposes strong warnings against use in physiologically vulnerable groups, specifically children, adolescents, and women who are pregnant or lactating. Use is conditional for those with impaired kidney function, requiring specific dose reduction as stated in the prescribing information.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Trizolin (Norfloxacin) is defined by official regulatory documentation covering impacts on drug exposure, metabolic clearance, and pharmacodynamic risk.

Official Interaction Restrictions

Classification Interacting Substances/Categories
Do Not Combine (Not Recommended) Nitrofurantoin (due to documented antagonism of antibacterial effect)
Use with Caution/Avoidance Class IA and Class III Antiarrhythmics (due to potential QTc prolongation risk)
Increased Risk of CNS/Seizure Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), including Fenbufen

Documented Pharmacokinetic Effects

  • Absorption Interference: Products containing multivalent cations (e.g., antacids with magnesium/aluminum, iron or zinc supplements, Sucralfate, Didanosine) significantly reduce the absorption of Norfloxacin, leading to lower plasma concentrations.
  • Metabolic Clearance Reduction: Norfloxacin is documented to inhibit the CYP1A2 enzyme. This reduces the clearance of drugs metabolized by this pathway, such as Theophylline, Caffeine, Clozapine, and Tizanidine, potentially increasing their systemic exposure.
  • Excretion Alteration: Concomitant use with Probenecid is associated with a diminished urinary excretion of Norfloxacin.

Timing and Diet-Based Constraints

  • Mandatory Separation: Multivitamins, mineral supplements, antacids, and Sucralfate must be taken at least two hours apart from Norfloxacin administration.
  • Food/Dairy: Administration relative to meals or milk must be separated by at least one hour before or two hours after ingestion, due to absorption interference.

Population-Specific Notes

The risk of tendonitis and tendon rupture when combined with Corticosteroids is specifically noted to be higher in elderly patients and those with renal impairment.

Mechanism of Action

Targeted Inhibition of Bacterial DNA Synthesis

The active component, Norfloxacin, functions as an inhibitor by selectively targeting and binding to two essential bacterial enzymes: DNA Gyrase (Topoisomerase II) and Topoisomerase IV. This interaction locks the enzymes onto the bacterial DNA, preventing them from repairing the final step of re-ligation (re-joining) the DNA strands. The resulting cascade of genetic damage arrests bacterial replication and transcription, inducing cellular death.


The Bactericidal Mechanism and Resulting Cellular Effect

The functional consequence of inhibiting the DNA enzymes is the establishment of a bactericidal effect—the physiological result is the swift killing of the pathogenic bacteria. The accumulation of irreversible DNA damage and the simultaneous blocking of chromosome segregation ensures that the bacteria cannot survive or divide. This mechanism establishes a bactericidal effect by causing the physical destruction of the bacterial cells rather than suppressing cellular growth.


Mechanisms of Constraint and Limitation

The drug's mechanism is constrained by two primary biological mechanisms of bacterial defense. First, mutations in the gyrA and parC genes can structurally alter the target enzymes, significantly reducing Norfloxacin's ability to bind and inhibit them. Second, the presence of active efflux pumps physically expels the drug from the bacterial cell, lowering the intracellular concentration below the level required to engage the target enzymes effectively, thus limiting the bactericidal cascade.

Dosage and Administration Information

Trizolin, which contains the active ingredient Norfloxacin, is used according to specific instructions that define the route, dose, and duration of therapy. The medicine is officially administered either orally as a film-coated tablet for systemic treatment or topically as an ophthalmic solution for local ocular use.

The tablet is typically used in a standard dose of 400 mg, administered every 12 hours, resulting in a maximum daily dose of 800 mg. The overall course duration is precisely defined by the specific regimen, ranging from short 3-day courses to extended 28-day regimens.

For proper systemic delivery, the oral tablet must be taken on a separated schedule. The tablet should be taken at least 1 hour before or 2 hours after meals, milk, or dairy products. Furthermore, the administration must be spaced two hours before or two hours after taking mineral-containing supplements or antacids to prevent impaired absorption. The tablet should be swallowed with a full glass of water, and patients must maintain adequate fluid intake throughout the course.

A frequency adjustment is required for specific populations; for example, patients with severely reduced kidney function (creatinine clearance le 30 mL/min/1.73 m^2) must have their dosing reduced to 400 mg once daily.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Clinical Research

The compound was examined in the context of chronic inflammatory conditions. The research evaluated the compound in relation to changes in inflammation markers and related symptoms in study populations.

Consultation with a healthcare provider is important before starting, stopping, or changing treatment, as the information presented describes research findings and not medical guidance.


Key Study Findings

Outcomes and Symptom Assessment

Studies have evaluated the compound in relation to pain associated with chronic inflammation, with research examining the time to observed changes in assessed outcomes.

Research has evaluated the compound’s utility in long-term management of the condition, with studies examining whether a reduction in symptoms persists over time. One study followed participants for two years to assess the persistence of the outcomes measured.

Tolerability and Safety Profile

The tolerability profile described in studies. Reported adverse events in clinical trials were generally mild to moderate in severity. Common adverse events included headaches and gastrointestinal upset.

Research has evaluated whether the dosing frequency used in studies was associated with patient compliance measures.

Combination Therapy

Research has evaluated whether combining this drug with Drug X yields different outcomes compared to monotherapy, with studies examining the time to reach remission.

The tolerability of this combination was assessed in study populations, with findings reported. Study protocols described specific criteria for participant eligibility.

Key Studies & References U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease (Context for combination therapy/long-term management)

Frequently Asked Questions (FAQ)

Common questions about Trizolin (FAQ)


Q: Can Trizolin cause changes in mood or sleep?

Official product documentation indicates that Trizolin can potentially affect the central nervous system (CNS). Reported side effects can include changes in mood such as anxiety, nervousness, depression, or psychotic reactions in rare instances. Difficulty sleeping, known as insomnia, is also listed as a potential side effect.


Q: Is it normal to feel a little dizzy when first starting Trizolin?

Dizziness is classified in regulatory labeling as a common adverse reaction, meaning it is one of the more frequently reported effects in clinical studies. Like other CNS (Central Nervous System) side effects, dizziness may be noticed soon after starting the medicine.


Q: Does Trizolin affect blood test results?

Official safety information indicates that temporary changes in lab test results can occur. These can include a transient or temporary elevation of liver enzymes (such as ALT/AST) and changes in white blood cell counts. These changes are generally assessed within the context of medical care.


Q: What information about Trizolin is still being studied or researched?

Research and safety monitoring of the medicine are ongoing through post-marketing surveillance and required studies. Official summaries indicate that research continues to examine the drug’s effects on specific patient groups and the long-term outcomes associated with its use.


Q: Are there specific times when Trizolin is not recommended?

Official warnings specify that the medicine can cause photosensitivity reactions, which are increased sensitivity to light. The labeling describes the potential for photosensitivity reactions, which are increased sensitivity to light. Official warnings state that exposure to excessive sunlight and artificial UV light (such as tanning beds) should be limited during use.


Q: Can Trizolin be taken at the same time as cold or allergy medicine?

Official documents warn that using Trizolin alongside Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), which are often found in cold and pain relievers, may increase the risk of CNS side effects like seizures. Additionally, antacids and mineral supplements common in some remedies must be taken at least two hours apart from Trizolin.


Q: How quickly does Trizolin start to work after taking it?

Clinical studies show that the active substance in Trizolin is rapidly absorbed into the bloodstream. Peak plasma concentrations are typically reached about one hour after taking an oral dose, and consistent, steady-state concentrations are generally attained within about two days of regular intake.


Q: How long do the effects of Trizolin typically last?

The duration of the active substance in the body is often described by its elimination half-life (the time it takes for half of the dose to be cleared). The half-life of Trizolin’s active ingredient in the plasma of healthy individuals is generally reported to be 3 to 4 hours.


Q: Is Trizolin generally safe for older adults?

Clinical studies found no substantial differences in the safety or efficacy profile between older subjects (65 years and older) and younger subjects. However, official labeling notes that older adults are considered to be at a higher risk for tendon rupture. Patients with reduced kidney function are noted as a population where dose adjustment may be necessary according to prescribing information.


Q: Do you have to take Trizolin every day?

Trizolin is prescribed for a specific course of therapy to eliminate the infection. Official dosing documents state that the total duration can range significantly, from short courses of three days to extended courses lasting up to 28 days, depending on the condition being treated.


Q: What should someone do if they miss a scheduled intake of Trizolin?

Patient information often describes a standard practice where, if a dose is missed, it can be taken as soon as it is remembered. If the time for the next scheduled dose is near, the official guidance often states to skip the missed dose and return to the regular schedule. The information warns against taking a double dose to make up for a missed one.


Q: What does the term 'non-directive use conditions' mean for Trizolin?

This term refers to the principle that public information about Trizolin remains strictly factual and educational. It means that while the medicine’s purpose, interactions, and safety profile are described, the content does not offer individual medical advice or specific instructions on how any particular person should use the medicine.


Q: Is Trizolin affected by what time of day it is taken?

The time of day is less critical than maintaining the prescribed interval between intakes to keep medicine levels consistent. However, administration is strongly affected by meals and supplements; it must be separated by at least one hour before or two hours after ingesting food, milk, dairy, or mineral-containing products.


Q: Are there generic versions of Trizolin available?

Trizolin is the brand name for the active ingredient Norfloxacin. In many major markets, generic versions of Norfloxacin have been developed, although actual product availability may vary by region.


Q: How is Trizolin absorbed and eliminated by the body?

After taking the medicine orally, the active ingredient is rapidly absorbed into the system. The body then eliminates the medicine through two primary routes: renal excretion (via the kidneys) and biliary excretion (via the bile), clearing it from the body.


Q: Can Trizolin interact with caffeine?

Official drug interaction information explicitly notes that Norfloxacin can inhibit the enzyme CYP1A2, which is responsible for breaking down substances like Caffeine. This inhibition can potentially lead to increased concentrations of caffeine in the body.


Q: Why do some people need a higher intake of Trizolin than others?

The medicine is generally prescribed at a standard dose. Regulatory documents mostly specify dose reductions (such as for patients with severe kidney impairment) rather than increases. However, the total duration of treatment, which varies based on the type and location of the infection, is the main difference in overall intake.


Q: Is Trizolin classified as a controlled substance?

Based on classifications in major regulatory jurisdictions, including the United States, Trizolin (Norfloxacin) is not classified as a controlled substance.


Q: What happens if someone accidentally takes too much Trizolin?

Official overdose information describes that close observation by a medical professional is generally indicated. Supportive care, adequate hydration, and potential measures like gastric emptying (stomach lavage) may be used. Hemodialysis is noted as generally not being highly effective.


Q: How is the safety of Trizolin monitored after it is approved?

Regulatory bodies use post-marketing surveillance systems to continually monitor the medicine after it is made available to the public. These systems collect and analyze reports of any adverse events and are used to update the official product labeling as new safety information emerges.


Q: Does Trizolin require a special diet while using it?

Official prescribing information indicates that a 'special diet' is not required. However, strict administration rules require separating the intake of Trizolin from all food, especially milk, dairy products, and mineral supplements, to prevent interference with drug absorption.


Q: Can Trizolin affect a person's ability to drive or operate machinery?

Due to the potential for central nervous system side effects like dizziness and drowsiness, official warnings advise caution. Official warnings state that due to the potential for these side effects, activities requiring mental alertness, such as driving or operating complex machinery, should be approached with caution.


Q: Do official sources describe any specific expectations about Trizolin's benefits?

Official regulatory documents indicate that the medicine is an antibacterial agent intended to treat infections caused by susceptible bacteria. The expected outcome is the elimination of the bacterial pathogen and the subsequent resolution of the infection's clinical signs and symptoms.


Q: Is Trizolin described as a cure for the condition it treats?

Official documentation describes Trizolin as an antibacterial agent intended for the treatment of infections. Regulatory language focuses on the drug's role in managing and resolving the infectious process, rather than labeling it with the general term 'cure'.


Q: Does Trizolin affect fertility in men or women?

Pre-clinical animal studies have examined the drug's effects on reproduction. While the medicine is strictly contraindicated during human pregnancy, the official prescribing information generally does not publish or conclude human data on the direct effect of Norfloxacin on fertility in adult men or women.


Q: Can Trizolin be crushed or cut in half if swallowing is difficult?

Trizolin is formulated as a film-coated tablet. Prescribing information for the film-coated tablet generally does not provide instructions for crushing, cutting, or altering the form of the tablet.


Q: Are there specific symptoms that indicate Trizolin is working?

The medicine is documented to have a bactericidal effect (killing bacteria). Therefore, the primary indication that Trizolin is working is the observed resolution of the clinical signs and symptoms that are characteristic of the infection being treated, which is assessed by a healthcare provider.

How should Trizolin be stored and disposed of?

How to Store and Dispose of Trizolin

The following requirements are based strictly on official regulatory labeling regarding the storage and disposal of Trizolin (Norfloxacin 400 mg tablets).

Official Storage Requirements

Condition Requirement
Temperature Store below 25 C.
Protection Keep protected from light and moisture.
Packaging Keep in the original container/blisters.
Stability Official shelf life is 3 years.
Child Safety Keep out of the reach of children.

Disposal Instructions

Official regulatory documents state there are no special requirements for the disposal of Trizolin. The product is not classified as a regulated hazardous pharmaceutical waste, and disposal should follow local municipal and pharmaceutical-waste guidelines.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Trizolin found in:

A-Z Index: